Chronic myeloid leukemia (CML) is characterized by the presence of the BCR-ABL1 fusion oncoprotein, a constitutively active tyrosine kinase [1, 2]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.